[Thrombolytic therapy].
de Gaetano
G
G
Donati
M B
MB
Gensini
G F
GF
Restagno
C
C
D016255:Anistreplase / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000191:economics; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000191:economics; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D016255:Anistreplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Terapia trombolitica.